Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
FDA Approves Merck’s KEYTRUDA® for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC).
Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B
11:00am, Monday, 22'nd Jun 2020
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduc
KEYTRUDA® Approved in China for Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Altimmune’s Largest Investor Sees Potential Coronavirus Vaccine, Buys More Stock
11:00am, Sunday, 21'st Jun 2020
Venrock Healthcare Capital paid $11.3 million for 1.5 million more Altimmune shares on June 15. It was buying shares of the biopharmaceutical firm in late May, as well.
The Global Biodefense Market will grow by $ 3.22 billion during 2020-2024
Are Options Traders Betting on a Big Move in Altimmune (ALT) Stock?
12:45pm, Wednesday, 17'th Jun 2020
Investors need to pay close attention to Altimmune (ALT) stock based on the movements in the options market lately.
How to buy Altimmune shares from Australia | 16 Jun price $7.68
02:28am, Tuesday, 16'th Jun 2020
Ever wondered how to buy shares in Altimmune in Australia? We explain how and compare the best share trading platforms.
NASDAQ Briefly Tops 10K and Finishes with New High
01:15pm, Wednesday, 10'th Jun 2020
NASDAQ Briefly Tops 10K and Finishes with New High
NASDAQ Reaches Record High, S&P Positive for 2020
01:15pm, Tuesday, 09'th Jun 2020
NASDAQ Reaches Record High, S&P; Positive for 2020
Merck Provides Update on Phase 3 KEYNOTE-361 Trial Evaluating KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Urothelial Carcinoma
Company to host conference call on Monday, June 1, 2020 at 8:30 a.m. GAITHERSBURG, Md., June 01, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today an
The
ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'
03:34pm, Thursday, 28'th May 2020
As the fallout from the coronavirus pandemic continues, the search for a vaccine is not slowing down.
6 Stock Charts to Watch: ALT, CAR, MGM, JETS, OVID, VLO
12:00am, Wednesday, 27'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ballard Power Systems Inc, MGM Resorts International, Darden Restaurants Inc. Read Harry Boxer's latest article on Investing.com
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:00am, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs on May 20.)
ADC Therapeutics SA (...
